+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Plasma Derivatives Market by Source (Plasma Derived, Recombinant), End User (Hemophilia Treatment Centers, Home Care, Hospitals), Distribution Channel, Product Type, Application - Global Forecast 2025-2030- Product Image
Blood Plasma Derivatives Market by Source (Plasma Derived, Recombinant), End User (Hemophilia Treatment Centers, Home Care, Hospitals), Distribution Channel, Product Type, Application - Global Forecast 2025-2030- Product Image
Sale

Blood Plasma Derivatives Market by Source (Plasma Derived, Recombinant), End User (Hemophilia Treatment Centers, Home Care, Hospitals), Distribution Channel, Product Type, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010980
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood plasma derivatives market is experiencing robust transformation, fueled by increasing clinical application diversity, innovation in production, and evolving global distribution strategies. Advances in biologics manufacturing and new stakeholder alliances are reshaping supply chain efficiency and therapeutic outcomes across major healthcare economies.

Market Snapshot: Blood Plasma Derivatives Market Growth and Dynamics

The blood plasma derivatives market grew from USD 523.83 million in 2024 to USD 576.03 million in 2025, with a projected compound annual growth rate (CAGR) of 9.88%, reaching USD 922.24 million by 2030. Market expansion is being driven by factors such as rising demand for targeted immunotherapies, demographic shifts, and the adoption of next-generation production technologies. Strategic collaborations between biotech firms, healthcare providers, and contract manufacturers are strengthening supply and accelerating innovation, while regulatory demands continue to shape production standards and market entry dynamics.

Scope & Segmentation of the Blood Plasma Derivatives Market

This report provides an in-depth breakdown of the key drivers, trends, and structure of the blood plasma derivatives market, with detailed segmentation by source, end user, distribution channel, product type, application, and region.

  • Source: Plasma derived and recombinant products, including Factor VIII and Factor IX.
  • End User: Hemophilia treatment centers, home care, and hospitals.
  • Distribution Channel: Hospital pharmacy, online pharmacies, retail pharmacy, and specialist clinics.
  • Product Type: Albumin, coagulation factors (Factor VIII, Factor IX, fibrin sealant), and immunoglobulins (hyperimmune, intravenous, subcutaneous).
  • Application: Hemophilia treatment, neurological disorders, and primary immunodeficiency support.
  • Regions: Americas (with sub-national detail for the United States), Europe, Middle East & Africa, Asia-Pacific.
  • Companies: Coverage includes CSL Limited, Grifols S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, Kedrion S.p.A., Biotest AG, LFB S.A., Bio Products Laboratory Limited, Shanghai RAAS, and China Biologic Products Holdings, Inc.

Key Takeaways for Senior Decision-Makers

  • Innovation in recombinant technologies and digital supply chain tools is enhancing operational agility and safety across production and distribution.
  • Rising prevalence of immunological and hematological disorders is increasing demand for specialized and scalable plasma therapy solutions.
  • Strengthened regulatory focus on safety, traceability, and ethical sourcing is impacting product development and market approval strategies globally.
  • Strategic partnerships—especially between academic research centers and commercial entities—are advancing product pipelines and broadening the range of plasma-derived therapies.
  • Regional diversification, especially expansion in Asia-Pacific and Latin America, is creating new avenues for sourcing, local manufacturing, and market growth.

Tariff Impact: 2025 Regulatory Measures and Market Outcomes

The introduction of United States tariffs in 2025 is reshaping global supply chains for blood plasma derivatives. These measures increase costs for imported biologics and intermediates, prompting suppliers to reevaluate sourcing strategies, invest in local fractionation capabilities, and renegotiate contracts. Cost pressures are also driving greater scrutiny over procurement, unit pricing, and the consideration of alternative therapies among healthcare providers and payers.

Methodology & Data Sources

Our mixed-methods research incorporates thorough secondary reviews of industry literature, regulatory filings, and company disclosures, combined with primary interviews from executives, clinicians, and stakeholders in plasma collection and distribution. Data triangulation, thematic analysis, and independent peer review are employed to ensure accuracy, depth, and actionable relevance in findings.

Why This Report Matters for Executive Strategy

  • Enables clear assessment of market growth drivers, regional opportunities, and operational risks for informed decision-making.
  • Provides strategic segmentation insights to support investment and product portfolio alignment with emergent demand and regulatory expectations.
  • Facilitates competitive benchmarking by examining recent developments across leading industry players and their evolving business models.

Conclusion

Executives can leverage this report to make data-driven decisions that support resilient supply chains and targeted innovation in a shifting blood plasma derivatives market. Comprehensive research and actionable insights position organizations for sustainable growth and improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging recombinant albumin therapies reducing reliance on donated plasma proteins
5.2. Expansion of immunoglobulin demand due to increased autoimmune disorder prevalence
5.3. Adoption of advanced viral inactivation technologies for enhanced plasma product safety
5.4. Regulatory harmonization efforts accelerating global approval of plasma-derived therapeutics
5.5. Strategic partnerships between plasma fractionation companies and biotech innovators
5.6. Rising use of hyperimmune globulins for infectious disease management and pandemic response
5.7. Shift towards subcutaneous immunoglobulin administration improving patient adherence and comfort
5.8. Implementation of digital plasma donor management platforms optimizing collection and tracing
5.9. Investment in single-use bioreactor systems for decentralized plasma fractionation capacity
5.10. Development of monoclonal antibody adjuncts integrating with plasma derivatives for targeted therapy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Plasma Derivatives Market, by Source
8.1. Introduction
8.2. Plasma Derived
8.3. Recombinant
8.3.1. Factor IX
8.3.2. Factor VIII
9. Blood Plasma Derivatives Market, by End User
9.1. Introduction
9.2. Hemophilia Treatment Centers
9.3. Home Care
9.4. Hospitals
10. Blood Plasma Derivatives Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacies
10.4. Retail Pharmacy
10.5. Specialist Clinics
11. Blood Plasma Derivatives Market, by Product Type
11.1. Introduction
11.2. Albumin
11.3. Coagulation Factor
11.3.1. Factor IX
11.3.2. Factor VIII
11.3.3. Fibrin Sealant
11.4. Immunoglobulin
11.4.1. Hyperimmune
11.4.2. Intravenous
11.4.3. Subcutaneous
12. Blood Plasma Derivatives Market, by Application
12.1. Introduction
12.2. Hemophilia Treatment
12.3. Neurological Disorders
12.4. Primary Immunodeficiency
13. Americas Blood Plasma Derivatives Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Blood Plasma Derivatives Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Blood Plasma Derivatives Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. CSL Limited
16.3.2. Grifols, S.A.
16.3.3. Takeda Pharmaceutical Company Limited
16.3.4. Octapharma AG
16.3.5. Kedrion S.p.A.
16.3.6. Biotest AG
16.3.7. LFB S.A.
16.3.8. Bio Products Laboratory Limited
16.3.9. Shanghai RAAS Blood Products Co., Ltd.
16.3.10. China Biologic Products Holdings, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BLOOD PLASMA DERIVATIVES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD PLASMA DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD PLASMA DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BLOOD PLASMA DERIVATIVES MARKET: RESEARCHAI
FIGURE 26. BLOOD PLASMA DERIVATIVES MARKET: RESEARCHSTATISTICS
FIGURE 27. BLOOD PLASMA DERIVATIVES MARKET: RESEARCHCONTACTS
FIGURE 28. BLOOD PLASMA DERIVATIVES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD PLASMA DERIVATIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HYPERIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HYPERIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 108. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 109. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 110. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 111. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 118. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 119. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 120. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 121. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 216. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 217. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 218. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 219. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 232. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 233. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 234. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 235. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 254. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 255. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 256. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 257. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 264. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 265. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 266. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 267. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 272. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 273. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 280. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 281. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 282. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 283. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Blood Plasma Derivatives market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Kedrion S.p.A.
  • Biotest AG
  • LFB S.A.
  • Bio Products Laboratory Limited
  • Shanghai RAAS Blood Products Co., Ltd.
  • China Biologic Products Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 576.03 Million
Forecasted Market Value ( USD ) by 2030 $ 922.24 Million
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033 - Product Image

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033

  • Report
  • 149 Pages
  • Global
From
Blood Plasma Derivatives Market Report 2025 - Product Image

Blood Plasma Derivatives Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bovine Blood Plasma Derivatives - Global Strategic Business Report - Product Image

Bovine Blood Plasma Derivatives - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From
Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Blood & Plasma Components Market by Product Type (Plasma Proteins, Platelets, Red Blood Cells), Application (Diagnostic, Research, Therapeutic), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Blood & Plasma Components Market by Product Type (Plasma Proteins, Platelets, Red Blood Cells), Application (Diagnostic, Research, Therapeutic), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From

About the Market

The Plasma Derivative market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma derivatives are products derived from human plasma, such as albumin, immunoglobulins, and clotting factors. These products are used to treat a variety of medical conditions, including hemophilia, immune deficiencies, and shock. Plasma derivatives are typically collected from healthy donors and processed in a laboratory setting. The process involves separating the plasma from the other components of the blood, such as red and white blood cells. The plasma is then further processed to create the desired product. The Plasma Derivative market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products. Companies in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.